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Background: ATP-binding cassette (ABC) transporters and P4-ATPases are two large and seemingly unrelated
families of primary active pumps involved in moving phospholipids from one leaﬂet of a biological membrane
to the other.
Scope of review: This review aims to identify common mechanistic features in the way phospholipid ﬂipping is
carried out by two evolutionarily unrelated families of transporters.
Major conclusions: Both protein families hydrolyzeATP, although they employ differentmechanisms to use it, and
have a comparable size with twelve transmembrane segments in the functional unit. Further, despite differences
in overall architecture, both appear to operate by an alternating access mechanism and during transport they
might allow access of phospholipids to the internal part of the transmembrane domain. The latter feature is
obvious for ABC transporters, but phospholipids and other hydrophobic molecules have also been found embed-
ded in P-type ATPase crystal structures. Taken together, in two diverse groups of pumps, nature appears to have
evolved quite similar ways of ﬂipping phospholipids.
General signiﬁcance: Our understanding of the structural basis for phospholipid ﬂipping is still limited but it
seems plausible that a general mechanism for phospholipid ﬂipping exists in nature. This article is part of a
Special Issue entitled Structural biochemistry and biophysics of membrane proteins.
1. Background
Biological membranes are the basis for highly deﬁned and separated
functional units. The cell membrane, or plasma membrane, deﬁnes the
external boundary of every cell separating the cytoplasm from the
surrounding environment. Eukaryotic cells contain in addition numer-
ous subcellular membranes that divide the cytoplasm into multiple
organelles, thereby allowing different functions to occur efﬁciently
and simultaneously in different parts of the cell. Almost all biological
membranes are organized as bilayers consisting of two leaﬂets structur-
ally formed byphospholipids. Depending on their (sub)cellular location,
they might also contain other types of phospholipids, including glyco-
lipids and sterols. A remarkable feature of many biological membranes
is that their phospholipids are asymmetrically distributed across the
lipid bilayer, a phenomenon known as transbilayer lipid asymmetry. A
prominent example is the plasma membrane of animal cells where
the phospholipids phosphatidylcholine (PC) and sphingomyelin (SM)
are concentrated in the exoplasmic leaﬂet while phosphatidylserine
(PS) and phosphatidylethanolamine (PE) are restricted to the cytosolic
leaﬂet [1]. Transbilayer lipid asymmetry is essential for several vital
cellular functions, including regulation of membrane protein activity,
signaling, and vesicle formation in the secretory and endocytic path-
ways [2–5]. In animals, loss of transbilayer lipid asymmetry has been re-
lated to processes like blood coagulation [6], macrophage recognition
[7] and apoptosis [8]. Establishing and maintaining the asymmetry is
thus crucial for the cells, and a number of proteins have evolved to fulﬁll
a role as cross-bilayer phospholipid transporters.
Transbilayer lipid asymmetry is largely controlled by a diverse group
of membrane proteins that catalyze the movement of phospholipids
acrossmembranes. Lipid translocators can be classiﬁed into two catego-
ries: (i) energy-independent transporters such as scramblases that ran-
domize the distribution of lipids across the bilayer and (ii) ATP-driven,
vectorial transporters that actively translocate speciﬁc lipids from one
leaﬂet to the other. The latter class of transporters includes ATP-
dependentﬂippases andﬂoppases,which catalyze inward phospholipid
movement to and outward phospholipid movement from the cytoplas-
mic leaﬂet of cellularmembranes, respectively. Current genetic and bio-
chemical evidence indicates that these proteins are primarily members
of the ATP-binding cassette (ABC) and P-type family of transporters
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(Tables 1 and 2). However, measuring phospholipid translocation is not
a trivial task, as the transporters are trapped in an environment (cellular
membranes) formed by their own substrate (lipids). Therefore, in intact
cells or organisms, assignment of phospholipid translocating activity is
in most cases based on the use of ﬂuorescent phospholipid analogs;
only few studies have attempted to measure transport of natural phos-
pholipids (Tables 1 and 2). Phospholipid transport observed in vivo
need not be directly linked to the activity of ABC transporters or P4-
ATPases, and might represent indirect effects. Only recently, advances
in puriﬁcation and reconstitution techniques have allowed demonstrat-
ing the capacity of some ABC transporters and P-type ATPases to directly
translocateﬂuorescent phospholipid analogs, providing thebest evidence
so far that these transporters indeed have phospholipids as a substrate.
2. Scope of review
Several excellent reviews have surveyed the physiological relevance
of phospholipid transporters recently [3,5,9]. Here, we will focus on
recent advancements in the determination of the structure and mecha-
nism of putative ATP-dependent phospholipid transporters.
3. ATP-dependent phospholipid transporters
Cellular, biochemical and recent reconstitution studies demonstrate
that various ABC transporters and P-type ATPases couple ATP hydrolysis
to translocation of speciﬁc phospholipids from one leaﬂet to the other
and thereby help generate membrane lipid asymmetry (Tables 1 and 2).
An important question arises when comparing the two classes of phos-
pholipid ﬂipping pumps: are their transport mechanisms the same or
has nature evolved different ways of translocating phospholipids across
the bilayer? In the next sections, we will review the main features of
ABC transporters and P-type ATPases implicated in phospholipid trans-
port and compare their putative transport mechanism(s).
3.1. ABC transporter family
The ABC transporter family is found in organisms throughout evolu-
tion and constitutes one of the largest superfamilies of integral mem-
brane transporters. The family includes a wide range of proteins that
share common structural features and transport a variety of organic
and inorganic substrates, including phospholipids (Table 1). Several
of these transporters are mutated in human disorders related to phos-
pholipid transport and metabolism, including Tangier disease [10],
Stargardt disease [11] and progressive familial intrahepatic cholestasis
[12]. The functional transport unit comprises two nucleotide-binding
domains (NBD), typical of ABC transporters, and two transmembrane
domains (TMDs), each containing ﬁve to ten membrane-spanning
regions (Fig. 1A). They can occur as one complete transporter, two
half-transporters, or four polypeptides.
3.1.1. General structural features of ABC transporters
The NBDs of all ABC transporters contain highly conserved amino
acid motifs. Each NBD contains two ATP-binding motifs: the Walker A
motif (GXXGXGK(S/T)) and the Walker B motif (hhhhDE, where h is a
Table 1
Evidence for ABC transporter-catalyzed phosholipid transport.
Transporter Lipid1 Movement,
membrane2
Approach Reference
Bacteria
MsbA Lipid A, PLs? Out, PM Intact cells; ATPase stimulation;
Reconstitution
[72,137–139]
PglK Lipid-linked oligosaccharides Out, PM Intact cells [140]
LmrA PE, Lipid A Out, PM Reconstitution;
E. coli complementation;
ATPase stimulation
[141,142]
Fungi
Pdr5p, Yor1p PE, Out, PM Intact cells [143,144]
Ybt1p PC Out, vacuolar Intact cells;
Isolated vacuoles
[145]
Cdr1p PE,PC,PS Out, PM Intact cells; Reconstitution [63,146,147]
Cdr2p PE,PC,PS Out, PM Intact cells [63]
Cdr3p PE,PC,PS In, PM Intact cells [63]
Leishmania donovani
LABCA1 PLs Out, PM Intact cells [148]
LABCA2 PLs Out, PM Intact cells [149]
LABCB4 PC Out, PM Intact cells [150]
LABCG2 PS Out, PM Intact cells [151]
LABCG4 PC Out, PM Intact cells; yeast vesicle assay [152]
LABCG6 PLs Out, PM Intact cells [153]
Mammals
ABCA1 PC, PS, SM Out, PM Intact cells;
reconstitution
[65,91]
ABCA3 PC, SM Out, lysosomal vesicles Expression in HEK-293 and A549 [154–156]
ABCA4 PE, N-retinylidene-PE In, Disk Reconstitution [64,65,157]
ABCA7 PS, (PC, SM) Out, PM Intact cells;
reconstitution
[65,158–160]
ABCB1 (MDR1) PLs, SLs, PAF Out, PM (apical) Intact cells; yeast vesicle assay; reconstitution [70,71,89,90,161–164]
ABCB4 (MDR3,Mdr2) PC Out, canalicular Intact cells; yeast vesicle assay [89,165–167]
ABCC1 (MRP1) PLs Out, PM (basolateral) Intact cells; reconstitution [168–171]
1 PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS, phosphatidylserine. PLs, phospholipids; SLs, sphingolipids; PAF, platelet-activating factor (1-Hexadecyl-2-acetyl-sn-
glycero-3-phosphocholine); SM, sphingomyelin. Substrate speciﬁcities are mostly demonstrated by the use of ﬂuorescent lipid probes. Evidences for translocation of natural lipids are in-
dicated in bold.
2 PM, plasma membrane; Disk, photoreceptor disk membranes.
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hydrophobic amino acid) [13,14]. TheWalker Amotif establishes exten-
sive interactions with the phosphate group of an ATP molecule [15,16].
The Walker B motif contains an aspartate involved in the coordination
of water and Mg2+ at the catalytic site and a catalytic glutamate
required for ATP hydrolysis [16–19]. A similar role in coordination has
a conserved glutamine at the Q-loop located between the Walker
sequences [16,19–21]. A conserved aromatic amino acid residue in the
A-loop upstream of the Walker A motif is involved in interacting with
the π-stack of the adenosine ring of ATP [22–24]. Downstream of
Walker B are the D-loop and the H (or switch)-loop that contain a
conserved aspartate and a conserved histidine, respectively, involved
in the coordination of the γ-phosphate either through interaction
with a water molecule (D-loop) [17,19,20,25,26] or through direct hy-
drogen bonding (H-loop) [19,27]. Finally, the ABC signature is a helical
subdomain located in between theWalker sequences of each NBD con-
taining the amino acid sequence LSGGQ, also involved in ATP binding
[28–33].
When the transporter binds ATP, the twoNBDs arrange in a head-to-
tail manner, generating the so-called “closed-dimer” conformation, in
which two nucleotide molecules are sandwiched in the interface
between the two NBDs and interact with residues from the Walker A,
Walker B, H- and Q-loops of one NBD and the D-loop and ABC signature
of the other [15,17,34]. Due to this arrangement some ABC transporters
show an allosteric behavior for hydrolysis of the two ATP molecules,
presumably controlled by the D-loop [26,33,35].
ABC transporters present three different types of structural folding,
depending on the organization of their transmembrane segments
[36,37]. Thus, it is possible to distinguish between an “exporter”
fold adopted by proteins involved in the transport of substrates away
from the cytoplasm, and twodistinct “importer” folds, typical of proteins
that transport substrates toward the cytoplasm.
The typical ABC “exporter” fold contains a total of 12 transmembrane
spanning α-helices that form the substrate binding site and provide the
pathway for the movement of substances across the membrane [36]
(Fig. 1A). TMDs from different transporters present low levels of homol-
ogy, probably reﬂecting the wide variety of substrates transported by
this protein family. The 12 membrane-spanning segments arrange into
two bundles of six with a large cavity in between that can either be
open-inwards (to the cytosol) or open-outwards (to the extracellular/
luminal side) (Fig. 1B). In the open-inwards conformation, each bundle
is commonly formed by interaction between transmembrane segment 4
(TM4) and TM5 of one half transporter or half monomer and TM3 and
TM6 of the other half. In this conformation, a 2-fold pseudo-symmetry
can be observed for TM1-3 with respect to TM4-6 for each individual
TMD [38–40]. During catalysis, the TMDs suffer extensive structural
rearrangement establishing a new interaction surface that changes the
orientation of the exposed cavity in the membrane [38,39,41–43]. This
reorganization results in the “open-outwards” conformation in which
TM1 and TM2 in one monomer now interact with TM3 and TM6 of the
other [44]. In the process, a high afﬁnity binding site for the substrate
in the “open-inwards” conformation changes into a low afﬁnity binding
site in the “open-outwards” conformation [45,46]. To date, only the bac-
terial ABC transporterMsbAhas been crystalized in both the inward and
outward facing conformations presumably adopted by the “exporters”
during the catalytic cycle (Table 3) [39]. However, the similarities
between the different structures suggest that the alternating-opening
conformations also exist for other transporters.
In ABC “exporters”, those TMDs that are not directly connected to
NBDs are extended byα-helices that stretch out into the cytoplasm be-
tween 25 and 40 Å away from the surface of the lipid bilayer [40,47,48]
(Fig. 1E and F). Such extendedα-helices are not found in the “importer”
fold, suggesting that they might be directly related to the exporter type
mechanism and, in some ABC exporters, they have been linked to recog-
nition of a soluble transported substrate [49–51]. All together, the
cytosolic protrusions of TMD helices generate four intracellular loops
(IL1–IL4) that contain the so-called coupling helices. These run parallel
to the plane of the membrane and interact with the NBDs [36,52,53].
Due to the twisted arrangement of the transmembrane spanning seg-
ments, IL2 and IL4, each located in a different half transporter or half
monomer, interact exclusively with the trans-NBD (in the opposite
half), while IL1 and IL3 only interact with the cis-NBD. Besides, TM6
ﬁnishes in a cytoplasmic α-helix extension located just upstream of
Table 2
Evidence for P4-ATPase-catalyzed phosholipid transport.
Transporter Lipid1 Movement,
membrane2
Approach Reference
Saccharomyces cerevisiae
Dnf1p PC, PE, (PS), LPC, LPE, LPS In, PM Intact cells [126,143,172,173]
Dnf2p PC, PE, (PS), LPC, LPE In, PM Intact cells [143,172–174]
Dnf3p PC, PE In, Golgi Puriﬁed vesicles [175]
Drs2p PS, PE In, Golgi Puriﬁed vesicles; Reconstitution [174,176]
Leishmania donovani
LdMT PC, PE, (PS) In, PM Intact cells [177,178]
Caenorhabditis elegans
TAT-1 PS In, PM Intact cells [179,180]
TAT-5 PE In, PM Intact cells [181]
Arabidopsis thaliana
ALA1 (PS) In, PM Yeast complementation [104,182]
ALA2 PS In, Prevacuolar compartment Yeast complementation [114]
ALA3 PS, PE, PC In, Golgi Yeast complementation [113,114]
Mammals
ATP8A1 PS, (PE) In, Golgi ATPase stimulation;
Yeast vesicle assay
[183–186]
ATP8A2 PS, PE Golgi, Disks Reconstitution [124,187,188]
ATP8B1 PS, (PE) PM (apical) Intact cells [115,189,190]
ATP8B3 PS PM Intact cells [191]
ATP11C PS PM Intact cells [192]
1 PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS, phosphatidylserine; LPC, lyso-phosphatidylcholine; LPE, lyso-phosphatidylethanolamine; LPS, lyso-phosphatidylserine.
PLs, phospholipids; SLs, sphingolipids; PAF, platelet-activating factor (1-Hexadecyl-2-acetyl-sn-glycero-3-phosphocholine). Substrate speciﬁcities are mostly demonstrated by the use
of ﬂuorescent lipid probes. Evidences for translocation of natural lipids are indicated in bold.
2 PM, plasma membrane; AM, apical membrane; Disk, photoreceptor disk membranes.
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the NBD domain of each half monomer [39,40,52]. These interactions
may allow for intramolecular communication between the NBDs and
the TMD within the ABC transporter.
ABC “importers” present twodistinct types of fold, Type I and Type II.
Type I transporters mediate uptake of relatively small substrates
(sugars, ions and amino acids) and are structurally represented by the
bacterial molybdate transporter ModBC [54,55]. They typically contain
12 transmembrane segments, arranged into two core bundles of ﬁve
helices in each half transporter or half monomer, with an N-terminal
extra helix that wraps around the TMD of the other half transporter or
half monomer [36]. In some cases, this extra helix is lacking, such as
for the E. colimethionine importer MetNI [56], or additional regulatory
helices might be present, as is the case for the bacterial maltose trans-
porter MalFGK2 [33,57]. Further biochemical and structural analyses
are required to understand the consequences of this phenomenon for
substrate movement.
Type II ABC “importers”, involved in the transport of much bigger
molecules, such as heme, metal chelates or vitamin B12, generally
Fig. 1.General structure of ABC transporters and P-type ATPases. (A) Secondary structure of ABC transporters. TheABC transporter exists both as amonomer full transporter and as a dimer
consisting of two half transporters. In either case, this type of transporter contains two transmembrane domains (TMD1 and 2), each harboring 6 transmembrane helices named 1 to 6 in
TMD1 and 1′ to 6′ in TMD2. Furthermore, two nucleotide binding domains (NBD1 and NBD2) are present on the cytosolic side of themembrane. NBD1 is either situated at the C-terminal
end of one half transporter or is connecting TMD1 and TMD2 in the full transporter; alternatively the domain architecture can have a reverse topology, i.e. NBD1-TMD1-NBD2-TMD2. (B)
Model of substrate translocation carried out by ABC exporters. First, the substrate enters the cavity between the transmembrane domains, which are facing the cytosol. At this stage the
transporter has high afﬁnity for the substrate. Second, the substrate is occluded in the ABC transporter. Third, through conformational changes a cavity is now opened toward the exocytic
side of themembrane the substrate speciﬁcity decreases and the substrate is being released. (C) Secondary structure of P-type ATPases. These transporters consist of one transmembrane
domain (TMD) with eight to twelve transmembrane helices labeled 1 to 12. Both the N- and C-terminal ends are facing the cytosolic side of the membrane. The cytosolic domain of the
transporter is divided into three major domains; The Actuator domain (A), the Nucleotide binding domain (N) and the phosphorylation domain (P). The P4-ATPases in addition to theα-
subunit consist of a β-subunit with two transmembrane spans and a large exoplasmic loop. (D) Model of ion transport through P-type ATPases. During the catalytical cycle the P-type
ATPases undergoes large conformational changes during which a half channel is ﬁrstly opened toward the cytosolic side of the membrane. In this conformation the transporter has
high afﬁnity for the transported substrate. The enzyme becomes phosphorylated and undergoes a conformational change leading to the occlusion of the substrate followed by a closure
of the half channel. An addition change in the conformation of the enzyme leads to the generation of an open half channel toward the exoplasmic side of themembrane in this conforma-
tion the substrate speciﬁcity decreases and the substrate is released. (E) Structural comparison between ABC transporters and P-type ATPases. Left, model of the yeast P4-ATPase Dnf1p
[118]; Right, Salmonella typhimuriumABC transporterMsbA (PDB code 3B60). (F) Schematicmodel of the position of intracellular loops (ILs) in an ABC exporter. Light and dark gray colors
represent the two independent halves of the transporter. ILs are designated by numbers (1–4). IL1 and IL2, corresponding to the ﬁrst half transporter, interact with the cis-NBD and the
trans-NBD, respectively. The same is the case for IL3 and IL4, corresponding to the second half transporter.
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contain 10 transmembrane helices in each half transporter, for a total of
20 hydrophobic helices in a full transporter [36]. Both Type I and Type II
importers present shorterα-helices than the known ABC exporters and,
at least the bacterial ones, require the presence of extracytosolic acces-
sory proteins involved in substrate loading [58–60].
In a similar manner as the ABC “exporters”, ABC “importers” have
been crystallized both in “open-inwards” and “open-outwards” confor-
mations, related to each order by rotation of the transmembrane do-
mains as a consequence of the formation of a closed dimer between
the NBDs [37]. Dimerization may be the result of ATP binding and its
disruption a consequence of ATP hydrolysis. Coordination of the TMDs
and the NBDs is achieved by the presence of two coupling helices
extending from the TMDs of each half transporter. The coupling helices
contain the so-called “EAA motif”, a sequence of 15–20 amino acid
residues considered to be a signature motif for ABC “importers” [61].
The EAA motif interacts with several residues in the NBDs, which are
speciﬁc for Type I or Type II importers [62].
At least two ABC “importers”, Candida albicans Cdr3p andmammali-
an ABCA4, appear to function as pumps catalyzing inward phospholipid
transport [63–65]. Interestingly, in contrast to Cdr3p, two other mem-
bers of the C. albicans Cdr family, Cdr1p and Cdr2p, have been character-
ized as outward phospholipid transporters [63]. Cdr3p possess 56 and
55% sequence identity to Cdr1p and Cdr2p, respectively, and based on
secondary structure predictions, would be expected to fold similarly to
these and other Cdr proteins [66]. Likewise, human ABCA4 and its
closest homologue, ABCA1, have a similar predicted architecture, but
transport phospholipids in opposite directions [65]. The transport
activity of both ABCA1 and ABCA4 was demonstrated after reconstitu-
tion of puriﬁed proteins in proteoliposomes in the absence of accessory
substrate binding proteins, which provides strong evidence that these
proteins are directly catalyzing phospholipid ﬂipping in opposite direc-
tions [64,65]. Does thismean that Cdr3p andABCB4present an “importer”
fold in contrast to their homologues, Cdr1p and ABCA4, respectively,
which would be predicted to present “exporter” folds? Membrane span
predictions and whole sequence homology show that the architecture
for these importers is not compliant with the bacterial importer type
but, notably, ABCA4 contains a conserved EAA amino acid motif that is a
signature for bacterial ABC importers [61,67]. It is possible that eukaryotic
ABC “importers” present the same fold as “exporters”, but have evolved
an inverse afﬁnity switch that allow them to transport the substrate
inwards. Indeed, it has been demonstrated that some plant ABC trans-
porters are capable of switching between the importer and exporter
mode depending on substrate concentrations [68,69].
Of the ﬁve ABC “exporters” crystalized as full proteins to date, two
have been shown to transport ﬂuorescent phospholipid analogs in
reconstituted systems (Tables 1 and 3) [70–72]. Due to the scarce infor-
mation available about eukaryotic phospholipid “importers”, in the
following we will only discuss the putative transport mechanism of
ABC “exporters”. For a more concise review on the structural folding
of ABC importers and its mechanistic consequences the reader is
referred to [36,73].
3.1.2. Putative catalytic mechanism of ABC transporters of the
“exporter” fold
The precise mechanism of coupling ATP binding and hydrolysis to
transport is still not completely understood. Two general models try
to explain this process: (i) the “ATP switch” model, and (ii) the
“constant contact”model. Common for both is that they are “alternating
access” models, according to which the pump alternates between two
major conformational states. In one state, the binding site for the
transported substrate faces one side of the membrane. In the other
state, the site faces the other side of the membrane. A number of other
proposals have been made that provide intermediate solutions for the
mechanism of transport of some ABC exporters. The reader is referred
to [53] for an extensive discussion on the subject.
According to the ﬁrst “ATP switch”model (Fig. 1B) [25,74], the NBDs
fully disassociate from each other during the catalytic cycle. Each cata-
lytic cycle starts with the TMDs in an open-inward conformation and
the NBDs separated from each other and none of them with bound
nucleotide. The high afﬁnity of the binding site will favor binding of
the substrate inside the cavity. Substrate binding results in a rearrange-
ment of the TMDs and repositioning of the NBDs, which allows for ATP
binding at both sites and formation of a closed-dimer intermediate. Ac-
cording to this model, binding of ATP and subsequent movement of the
NBDs into the closed-dimer conﬁguration provides the power stroke
that forces the transmembrane segments of the TMDs to close the cavity
facing the cytoplasm and assume an open-outwards conformation.
Rearrangement of amino acid residues with respect to the substrate
during movement of the TMDs eliminates the high afﬁnity binding
site, which has the consequence that the substrate gets released to the
extracellular side of the membrane. Finally, hydrolysis of either one or
both molecules of ATP disrupts the closed NBD dimer and restores the
ABC transporter in its original conﬁguration. The driving force for this
reaction comes from an increase in negative charge at the NBD due to
the formation of ADP and Pi with subsequent electrostatic repulsion
[75].
Although the ATP switch model can explain the action of many ABC
transporters, it is still highly debated. Recent crystallographic character-
ization of human ABCB10 and the heterodimeric transporter TM287/
288 from Thermotoga maritima suggests that the two NBDs are never
far apart from each other during the catalytic cycle [40,48], in contrast
with what was indicated by the apo-structures of MsbA and P-
glycoprotein [39,47,76]. Moreover, it is still unclear whether it is ATP
binding or ATP hydrolysis that actually drives conformational changes
accompanying substrate translocation. The crystal structures of bacterial
Sav1866 and MsbA in the presence of the non-hydrolysable ATP analog
AMP-PNP present an open-outwards conformation [39,45]. This would
suggest that ATP binding is sufﬁcient to stabilize the open outwards
conformation implying that the power stroke for conformational change
happens before ATP hydrolysis. In contrast, crystallization of human
ABCB10 and the heterodimeric Thermotoga transporter TM227/228
in the presence of the same ATP analog results in proteins locked in
the open-inwards conformation [40,48], which in analogy with the
Table 3
Available crystal structures for ABC transporters of the exporter fold.
Protein Conformation PDB entry⁎ Reference
Sav1866 Outward facing 2ONJ (3.40) [45]
Inward facing 2HYD (3.00) [41]
MsbA Outward facing 3B60 (3.70), 3B5Y (4.50), 3B5Z (5.20) [39]
Inward facing 3B5W (5.30), 3B5X (5.50) [39]
TM287/288 Inward facing 3QF4 (3.90) [48]
ABCB10 Inward facing 3ZDQ (2.85), 4AYW (3.30), 4AYX (2.90), 4AYT (2.85) [40]
P-glycoprotein Inward facing 3G61 (4.35), 3G60 (4.40), 3G5U (3.80), 4F4C (3.40), 4KSC (4.00),
4KSB (3.80), 4LSG (3.80), 4M1M (3.80), 4M2S (4.40), 4M2T (4.35), 4KSD (4.10)
[47,76,193,194]
CmABCB1 Inward facing 3WME, 3WMF, 3WMG (2.40/2.60) [93]
⁎ Numbers in brackets indicate structure resolution in Å.
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assumption above would indicate that ATP hydrolysis is required for the
large conformational change.Whether these differences are due tomech-
anistic reasons or just an artifact of crystallization remains to be elucidat-
ed. Indeed, molecular dynamics simulations with human ABCB1 have led
to the proposal that the verywide open-inwards conformationsmay rep-
resent non-physiological states that are stabilized by crystal lattice con-
tacts [77].
According to the second “constant contact model”, the two NBDs do
not dissociate from each other during catalysis, and each ATP binding
site hydrolyze ATP and open alternately [78,79]. This implies that a
single catalytic cycle does not imply binding, hydrolysis and release of
the same ATP molecule. Instead, in each transport cycle, one of the
NBDs will hydrolyze a bound ATP, while the other NBD will unload
ADP and Pi produced at this site during the previous catalytic cycle. In
order to promote ADP and Pi release, the NBD containing hydrolyzed
ATP rotates outwards which in turn forces the pump to acquire an
inward-open conformation, as shown in the crystal structures of
MsbA. The proposal that the NBDs never become distantly separated
from each other is supported by the ABCB10 structures [40]. The bio-
chemical and biophysical evidence supporting the “constant contact
model” has been reviewed recently [80].
ABC “exporters” seem to have a stoichiometry of one to two mole-
cules of ATP hydrolyzed permolecule of transported substrate. However,
it has been shown that some of these transporters can be partially
uncoupled in reconstituted systems [81,82]. A quest to understand the
uncoupling process has led to extensive evidence that the two NBDs
bind and hydrolyze ATP in a cooperative manner [83–86].
3.1.3. Putative phospholipid ﬂipping mechanism of ABC transporters of the
“exporter” fold
Although many details are known about the mechanism by which
ABC exporters carry out ATP hydrolysis and transduce the rearrange-
ment of the NBDs to the TMDs, very little is known about transport of
the substrate. Of the ﬁve ABC transporters of the exporter fold crystal-
lized to date only bacterial MsbA and P-glycoprotein (ABCB1) have
been shown to transport lipidic substrates. Depletion of cellular MsbA
or the presence of a conditionally inactivating mutation in this protein
result in loss of lipid A and phospholipid transport from the cytoplasmic
to the outer membrane in bacterial cells, suggesting a general ﬂippase
function for MsbA [87,88]. This evidence is conﬁrmed by reconstitution
experiments, in which MsbA has been shown to translocate a wide
variety ofﬂuorescent-labeled phospholipids, albeitwith low activity [72].
In the case of P-glycoprotein, studies in cell lines and reconstituted
systems have suggested the involvement of this protein in transport of
a variety of phospho- and glycolipids [65,70,89–91]. However, this pro-
tein was ﬁrst identiﬁed as the multidrug resistance transporter responsi-
ble for the inefﬁciency of long-termpharmacological treatments [92]. The
ﬂexibility in the recognition of substrates complicates greatly the task
of deﬁning a putative binding site for phospholipids within one of these
crystal structures. Furthermore, most crystal structures for ABC
“exporters” have a relatively low resolution (Table 3), which do not
allow for conﬁdent modeling of the position of the amino acid chains. It
has not been until very recently that the barrier of 3 Å resolution was
broken and a putative entry pathway for an amphipathic substrate was
proposed for the mitochondrial putative di-peptide transporter ABCB10
[40]. Recently, the crystal structure of an inward open half-sizemultidrug
transporter, CmABCB1, was solved at 2.6 Å resolution, which, supported
by mutant and transport analyses, revealed the structural basis for drug
substrate gating [93]. Interestingly, a cavity lies exactly within the hydro-
philic heads of the lipids and corresponds to the MsbA stretch where Cys
mutants showed decreased basal activity [94].
Two speculative models on ABC-type ﬂippases have been proposed,
the “tiltingmodel” and the “rotating helixmodel”, that are however not
exclusive [93,216]. In the tiltingmodel, a variation of the alternating ac-
cess model, the lipid enters the chamber of MsbA from the inner leaﬂet
of the bilayer. ATP binding causes conformational changes of the TMDs,
leading to the release of the substrate into the outer space (see Fig. 1B).
In the rotating helix model, conformational changes of ABCB1 lead to
the rotation of the TM helices reorienting the substrate-binding site
from the inner leaﬂet of the lipid bilayer to the outer, from where the
substrate is released.
Data from the ABCB1 structures revealed substantial TM helices
repacking upon nucleotide binding, which is consistent with the rotat-
ing helix model [95]. However, in respect to the signiﬁcant size of
most lipids but especially the lipid-A core transported by MsbA, it
seems likely that the ﬂippase ABC does not completely enclose the
lipid substrates, which is better covered by the alternating access
model. This has been widely accepted for other ﬂippases and is further
supported by structural data on MsbA employing spin labeling and
EPR [94]. However, the ﬁnding that both crystal structure and EPR
studies indicate large conformational changes in MsbA that correlate
with the huge size of the MsbA lipid-A substrate, might simply indicate
that MsbA and ABCBs employ distinct ﬂippase mechanisms.
Mutations in phospholipid binding domains should have a striking
impact on the activity and substrate speciﬁcity of ﬂippases. Site-directed
mutagenesis has been carried out extensively in MsbA and substitution
of a number of residues affected catalytic turnover by this transporter
[94]. However, as only basal ATP hydrolytic activity was determined, it
remains to be shown that in this systemATPhydrolysis is strictly coupled
to transport. Interestingly, the suggested lipid–drug duality of ﬂippases
has been explained by a coupling of phospholipid transportation and
drug transport [96]. According to this assumption ABCB1 would act as a
phospholipid ﬂippase caused as a side effect of its main drug transport
function, while the opposite would hold true for MsbA [97].
In all ABCB10 structures, TM1-3 and TM6 of onemonomer associate
with TM4 and TM5 of the other monomer [40]. In the structure of the
ABCB10 homodimer in the absence of bound nucleotide, TM1 and
TM2 are separated from each other by a maximal distance of almost
14 Å, enough for an amphipathic substrate to be bound between the
transmembrane loops. This distance is kept in a structure in which the
NBDs are bound to the non-hydrolysable ATP analog AMP-PCP
(Fig. 2A). Interestingly, the latter structure shows some electron density
in the region between TM1andTM2 that canbemodeled to the aliphatic
chain of a cardiolipin molecule (Fig. 2A). Although ABCB10 has never
been implicated in the transport of cardiolipin, the structure demon-
strates the possibility for the aliphatic chain of a lipid-like amphipathic
substrate to penetrate sideways from the membrane into the TMD of
the ABC exporter. Sequence homology alignments between different
members of the ABCB family of ABC transporters have identiﬁed the
presence of highly conserved residues in TM1-3 that have been sug-
gested to form part of the substrate binding region (Fig. 2A) [40].
These residues are located toward the cytosolic side of the large central
cavity of the ABC dimer where they have been proposed to coordinate
the hydrophilic part of an amphipathic substrate, whereas its hydropho-
bic region could be accommodated in the gap formed by TM1 and TM2
(Fig. 2A). In a third structure, crystallized in the presence of the ATP
analog AMP-PNP, the distance between TM1 and TM2 is reduced to
about 9 Å, which suggests a conformation wherein the entry pathway
is closed to prevent the substrate frommoving back into themembrane
before transport to the other leaﬂet takes place [40].
The proposed transport mechanism of ABCB10 is in agreement with
the rotating helix model, in which rotation of the TMDs during the cat-
alytic cycle allows for alternating opening not only of a central cavity,
but also of lateral entry and exit pathways for the transported phospho-
lipid substrate [95]. Unfortunately, all structures obtained for ABCB10
are in an open-inwards or closed-inwards conformation with the
TMDs forming a central cavity opened to the cytosolic side, and the ab-
sence of a structure in the proposed open-outwards conformation limits
our understanding of the catalytic cycle and how the transported sub-
strate is delivered back to the membrane. However, although the
AMP-PNP bound form of ABCB10 presents a closed-inwards conforma-
tion, the AMP-PNP-bound forms of the bacterial “exporters” MsbA and
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Sav21866 showanopen-outwards conformation,where the TMDs rear-
range to create a substantial central cavity opened to the exoplasmic
side of the membrane (Fig. 2A). TM1 and TM2 for one monomer, now
associate with TM3–TM6 of the other monomer. TM3 and TM4 are
now forming a lateral opening analogous to the one formed by TM1
and TM2 in the open-inwards conformation of ABCB10, which would
allow for lateral exit to the membrane environment of a transported
amphipathic substrate. Further biochemical and structural characteriza-
tion is required to understand whether these gaps between transmem-
brane domains actually form pathways for entry and exit of the
substrate.
3.2. Phospholipid ﬂippases of the P-type ATPase family
P4-ATPases constitute a major group of phospholipid ﬂippases that
are not related to ABC transporters. Rather, they belong to the P-type
ATPase superfamily, a large family of ATP driven biological pumps,
which transport a number of different substrates but share the common
feature that they form a phosphorylated intermediate during their
catalytic cycle [98]. P-type ATPases are divided into ﬁve subfamilies
(P1 to P5) characterized by their transported substrate [98]. P1 to P3-
type ATPases are cation transporters, such as the heavy metal trans-
porters involved in cytoplasm detoxiﬁcation and loading of metals
inside speciﬁc tissues and cellular compartments (P1-ATPases), the
sarcoendoplasmic reticulum Ca2+-ATPase (SERCA; a P2-ATPase)
involved in maintaining calcium homeostasis during signaling, the
plasma membrane Na+/K+-ATPase (a P2-ATPase) that generates the
membrane potential in mammalian cells, and the plasma membrane
H+-ATPase energizing plant and fungal cell membranes (a P3-
ATPase). Recently, structured logistic regression has been used as a ma-
chine approach to identify all P-type ATPases in the UniProtKB database
and classify them in P-typeATPase subfamilies [99]. Using this automat-
ed method less than one hundred prokaryotic sequences can with low
statistical signiﬁcance be classiﬁed as P4- and P5-ATPases [95], but indi-
vidual inspection of the sequences identiﬁed so far reveals that they all
show higher overall homology to P2-ATPases than to P4-ATPases. We
can thus conclude that while cation transporters of the P-type family
are found in all three branches of life, members of the P4- and P5-
ATPase subfamilies are only present in eukaryotic organisms. Whereas
the transported substrate of P5-ATPases remains to be determined,
P4-ATPases act as inward phospholipid transporters (Table 2).
3.2.1. General structural features of P-type ATPases
In contrast to ABC transporters, the catalytic subunit of P-type
ATPases is always encoded by a single polypeptide (Fig. 1C). Several
crystal structures are available that allow for visualization of various
pump proteins at different steps during the catalytic cycle (Table 4).
Even though the published P-type ATPase crystal structures show char-
acteristic individual peculiarities, they all exhibit a common fold. Thus,
four distinct structural regions, ﬁrst deﬁned and named by Toyoshima
et al. (2000) [100], are present in all P-type ATPases (Fig. 1C): a mem-
brane domain (M), that forms the pore through which the substrate is
transported; a variable nucleotide-binding domain (N), that functions
as a built-in protein kinase that phosphorylates the pump and where
ATP docks mainly through hydrophobic stacking of the adenosine ring
to a conserved phenylalanine; a phosphorylation domain (P) that con-
tains the conserved amino acid sequence DKTG including the aspartate
residue that gets phosphorylated during catalysis (hence P-type) and
two other conservedmotifs TGDN and GDGXND involved in the coordi-
nation of a Mg2+ ion required for ATP binding at the phosphorylation
site; and a built-in protein phosphatase, named the actuator domain
(A), comprising the amino acid sequence TGE, in which the glutamic
acid generates a nucleophilic attack on the phosphorylated aspartate
and causes dephosphorylation of the P-type pump. These four regions
are connected to each other with amino acid linkers and suffer dramatic
movements during the catalytic cycle, which involves twomain protein
conformations, Enzyme 1 (E1) and Enzyme 2 (E2), inwhich the substrate
binding site presents different substrate afﬁnities and is open to oppo-
site sides of the membrane (Fig. 1D).
The conformational transitions between E1 and E2 are large and
require very ﬂexible pump molecules. For some P-type ATPases, the
N- and/or C-terminal domains are autoinhibitory, preventing the con-
formational changes required for substrate transport by establishing
intramolecular interactions with other parts of the P-type ATPase
[101,102]. These autoinhibitory domains contain regulatory sequences
that interact with accessory proteins, such as calmodulin or 14-3-3
proteins in order to trigger activation of the pump [103].
Like other P-type ATPases, P4-ATPases are predicted to have 10
transmembrane spanning segments and both N- and C-termini facing
the cytosol [104]. The A-domain is formed by amino acid residues located
at the N-terminal domain and the intracellular loop between TM2 and
TM3, while the P- and N-domains are located to the intracellular loop
between TM4 and TM5 [10399].
3.2.2. General catalytic cycle of P-type ATPases
The SERCA1 Ca2+ pump from rabbit skeletalmuscle is by far the best
structurally characterized P-type ATPase. Not only E1 and E2 forms of
the protein have been crystallized, but also a large number of interme-
diate conformations representing almost all possible protein move-
ments and interactions with the transported substrate, ATP or its
hydrolysis products (Table 4). Taken together, this wealth of structural
information makes it possible to outline a detailed mechanism for the
action of this pump [105].
The catalytic cycle of cation transporting P-type ATPases starts when
the protein in the E1 conformation binds the substrate at theM-domain
in a high afﬁnity site opened to the cytosolic side of themembrane [106,
107]. This event initiates a structural rearrangement that is transmitted
across the pump molecule and makes possible the phosphorylation of
the P-domain by an ATP molecule already bound at the N-domain,
generating the E1P conformation. Transition into the E2P state occurs
when the A-domain rotates almost 120° and forces a reorganization of
theM-domain, which brings the active site of the built-in protein phos-
phatase of the A-domain in close proximity to the phosphorylated
aspartyl group. This reorganization results in an initial occluded state
in which the ion is blocked inside the protein and, subsequently, the
opening of a low afﬁnity binding site to the exoplasmic side of themem-
brane, which causes release of the bound cytosolic substrate and, in
some cases, binding of a counter-ion. Nucleophilic attack of the A-
domain onto the phosphorylated aspartate leaves the protein in the
E2 conformation that is unstable and transitions to the E1 conformation
forcing the A-domain to rotate back to its original position. Movement
of the A-domain results in reorganization of the M-domain, with the
consequent release of the exoplasmic substrate (the counter-ion) to
the cytosolic side of the membrane, see [108] for further detail.
Although no crystal structure is available for a P4-ATPase, these pro-
teins are probably not very different in folding from other members of
the P-type ATPase family, as suggested by the fact that (i) all P-type
ATPases including P4-ATPases have conserved core sequence segments
that are essential for catalysis [98,109], and (ii) all crystallized P-type
ATPases show a very similar tertiary structure despite their varying
TMD numbers and diverse substrates ranging from protons to heavy
metals [108,110]. Thus, assuming an analogous transport mechanism
for P4-ATPases as for the SERCA pump, the phospholipid would occupy
the place of the counter-ion and therefore be bound in the E2P confor-
mation at the exoplamic side of themembrane and released in the tran-
sition step to E2 on the cytosolic side.Whether an additional substrate is
transported in the opposite direction is yet unknown.
3.2.3. Putative phospholipid ﬂipping mechanism of P4-ATPases
In contrast to the different cations transported bymembers of the P1
to P3 subfamilies of P-type ATPases, phospholipids are voluminous sub-
strates that contain both a substantial hydrophilic head group and two
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long fatty acid chains of a hydrophobic nature (Fig. 3C). It is difﬁcult to
envisage how such a substrate can be introduced inside a protein
pore opened to one side of themembrane, be entirely occluded during
the structural transition of the protein through the catalytic cycle, and
then exposed to the other side of the membrane for its release. So
how do P4-ATPases manage their substrate?
A characteristic feature of P4-ATPases is the presence of a β-subunit
required for the catalytic cycle. This protein belongs to the family of
yeast Cdc50 proteins and contains two transmembrane domains and a
large luminal loop that is heavily glycosylated [111] (Fig.1C). Topologi-
cally, this protein resembles a fusion of the β- and γ-subunits of mam-
malian Na+/K+-ATPases [112]. As in the case of the Na+/K+-ATPase
β-subunit, the Cdc50 protein is required for proper folding and exit of
the P-type ATPase from the ER [111,103–116]. For the Na+/K+-
ATPase, the γ-subunit is involved in the modiﬁcation of the kinetic
parameters of cation transport depending on tissue and environ-
mental conditions [117–119]. For the yeast P4-ATPases, the Cdc50
protein is strictly required for the generation of a phosphorylated inter-
mediate and consequently for phospholipid transport, although it is not
clear how this protein contributes to P4-ATPase activity [120,121]. It has
been suggested that the Cdc50 protein is interacting with the
transported phospholipid and responsible together with the P-type
ATPase of generating a pathway for movement of the phospholipid
through the membrane [121]. However, phospholipid speciﬁcity
determinants for the P4-ATPase/β-subunit complex reside solely in the
P-type protein [114,122], which makes it improbable for the β-subunit
to directly participate in substrate binding during transport. Most likely,
the β-subunit is required for stabilizing the P4-ATPase in some of the
intermediate conformations during catalysis [123].
Recent mutational studies suggest two pathways by which P4-
ATPases could transport their substrate (Fig. 3): (i) the canonical
pathway with the phospholipid transported through the interior of
P4-ATPases in analogy with the cation transport mechanism of well
characterized P2-ATPases and (ii) a non-canonical pathway at the
protein–membrane interface. An increasing amount of biochemical
evidence seems to suggest that these two extreme models might be
partial descriptions of the same mechanism.
In the thoroughly studied Ca2+- and Na+/K+ transporting
P2-ATPases, the cation binding sites are present in small central cavities
primarily formed by charged or polar residues in the center parts of
transmembrane segments TM4, TM5, and TM6 [105]. Conserved acidic
group(s) positioned in the middle of TM4 and TM6 secure charge neu-
tralization of the transported cation, while two conserved asparagine
residues in TM5 and TM6 provide oxygen groups for ion coordination.
Further coordination is provided by backbone carbonyl oxygen atoms
in TM4, that contains one or more highly conserved proline residues
that function as helix-breakers [103]. Likewise, all P4-ATPases contain
a conserved proline in themiddle of TM4 (Pro-507 in Drs2p) suggesting
the presence in these pumps of a central cavity with carbonyl oxygens
contributing to the coordination of a hydrophilic group.
In contrast, P4-ATPases do not have preserved acidic residues in
their predicted transmembrane segments [109]. However, a basic lysine
residue (corresponding to Lys-1018 in the yeast P4-ATPase Drs2p; Lys-
873 in the mammalian photoreceptor P4-ATPase ATP8A2) is conserved
in all P4-ATPases and situated in themiddle of TM5 at the same position
as cation-coordinating residues in P2-ATPases [124]. Mutation of this
residue has a dramatic negative impact on the apparent afﬁnity of
ATP8A2 for its substrate PS as judged by the ability of the substrate to
induce dephosphorylation, or stimulate ATPase activity [124]. The bind-
ing energy of the substrate has to be transduced to the cytosolic
domains in these assays, and either the binding or transduction could
be perturbed by the mutation [124]. Given that several P4-ATPases
tolerate drasticmodiﬁcations of the acyl chains of the phospholipid sub-
strate, this model would imply considerable ﬂexibility of P4-ATPases to
accommodate their substrate and especially the phospholipid tail when
it traverses the membrane.
In contrast to this, substitution in the yeast P4-ATPase Dnf1p of the
conserved lysine in TM5 (Lys-1194) results in a reduction of protein
activity, but does not affect substrate speciﬁcity, suggesting that this
residue is not directly binding the substrate [125]. Further mutational
studies of Dnf1p identiﬁed amino acid residues involved in substrate
selection at the lumenal side of TM1 and the cytosolic sides of TM1,
TM2, TM3 and TM4, but not within the membrane region [122,125].
Two main residues determine the speciﬁcity of the Dnf1p protein: a
tyrosine close to the cytosolic side of TM4 (Tyr-618 inDnf1p) and a phe-
nylalanine in the loop that connects TM3 and TM4 (Phe-587 in Dnf1p).
Mutation of Tyr-618 to phenylalanine (the corresponding residue in the
PS-transporting P4-ATPase Drs2p) confers Dnf1 the ability to transport
PS, without affecting PC and PE translocation, while mutation of Phe-
587 reduces PC recognition without affecting PE. This feature has led
to the proposal of a two-gate system thatwould recognize the phospho-
lipid on one side of themembrane, allow it to slide to the other sidewith
the hydrophobic tail always protruding through a cleft toward the phos-
pholipid bilayer and then release it on the other side of the membrane
[125].
Indeed, a combination of biochemical analysis of mutants and pro-
tein modeling has been recently used to suggest a mechanistic model
in which a conserved isoleucine in TM4 (corresponding to Ile-364 in
the mammalian photoreceptor P4-ATPase ATP8A2) and its adjacent
residues form a hydrophobic gate that allows the formation of alternat-
ing water-ﬁlled cavities on both sides of the groove formed by TM1,
TM2, TM4, and TM6, similarly to the cation-gating role ascribed to the
Fig. 2. Putative lipid translocating pathways for an ABC exporter. (A) In the Rod A crystal structure of ABAB10 (PDB code 4AYT), a lateral opening between TM1 and TM2 shows electron
density that can be assigned to a cardiolipin molecule (dark blue). A putative lipid would be loaded by inserting its fatty acid tail in an analogous manner, while the head group interacts
with hydrophilic residues (green). (B) A closing of the gap between TM1 and TM2 results in occlusion of the lipid as suggested by the plate form crystal structure of ABCB10 (PDB code
4AYW). (C) Based on the crystal structure of MsbA in the presence of AMP-PNP (PDB code 3B60), rotation of the alpha helices in the TMD generates a lateral opening to the membrane
between TM3 and TM4 that can be used to unload the lipid.
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conserved glutamate residue present at the same position in other
P-type ATPases [126]. Thesewater-ﬁlled cavities would protect the hy-
drophilic phospholipid head group from the hydrophobic environment
during its passage through the membrane, while the phospholipid tails
protrude freely into the hydrophobic environment.
Further studies on the cooperation of Tyr-618with other residues of
TM1–TM3 has demonstrated that a number of amino acid residues
located on the cytosolic side close to theM-domain contribute to a pro-
posed exit gate for the phospholipid [127]. These residues also allow
Dnf1p (and its homologue Dnf2p) to discriminate between mono- and
di-acylphospholipids, which lead to the proposal that these yeast P4-
ATPases function primarily as lyso-lipid transporters [127]. Based on
homology modeling using the Na+/K+-ATPase as a template, these
residues were mapped to a region of the SERCA Ca2+-ATPase that
forms a binding pocket for a PE molecule in the E2 conformation [127,
128]. This PE molecule has been proposed to assist Ca2+ entry into a
deep, funnel-shaped and negatively charged path that leads to the
Ca2+ coordination sites located halfway through themembrane bilayer
[128,129]. The binding pocket is not accessible in the E1 conformation,
implying that the PE molecule has to dynamically enter and exit the
pocket as the SERCA Ca2+-ATPase proceeds through the catalytic
cycle. It is possible that this original phospholipid head group binding
pocket and cation-loading funnel have evolved in P4-ATPases to gener-
ate a cleft for phospholipid translocation. Indeed, the homology model
for Dnf1p in the E2 conformation shows a triangular shaped groove
ﬂanked by TM1 and TM3 on the sides and TM4 on the back [122].
Although the Dnf1p structural model has proven useful to identify
residues for biochemical studies, conclusions based on it need to be
carefully assessed, as the protein shows only 17% identity to the Na+/
K+-ATPase used as a template. Further, the model cannot explain
some of themost recentmutagenesis results. TwoDnf1p residues located
inside the membrane plane in TM2 (Thr-254 and Asp-258) are involved
in discrimination of lysophospholipids [127]. However, in the model,
TM2 is located behind TM1 and has no access to the groove formed by
TM1, TM3 and TM4, where the phospholipid is suggested to bind.
Interestingly, SERCA has been crystalized in the E2 conformation
with bound thapsigargin, a potent inhibitor of the SERCA pump with
phospholipid like features (Fig. 4, in blue) [128]. This crystal structure
also shows electron density that can be assigned to a PE molecule
(Fig. 4, in green). While PE is localized in a groove formed by TM2 and
TM4 with TM1 covering the backside, thapsigargin binds in a similar
groove on the opposite side of the M-domain, with TM3 and TM6
forming the sides and TM5 at the back. Notably, the acyl chains of
thapsigargin sit deeply between the transmembrane sections of the
SERCA Ca2+-pump, which would be consistent with high structural
ﬂexibility [128]. Whether the position of the transmembrane segments
in P4-ATPaseswould allow for binding of a phospholipid (and its subse-
quent transport) in a position analogous to that of PE or tharpsigargin in
SERCA still needs to be demonstrated andwould require the solution of
a crystal structure for one of these proteins. However, it seems possible
that P4-ATPases have evolved to generate a pathway through themem-
brane that would connect both binding sites, allowing for phospholipid
movement across them.
3.3. Comparison of ABC transporters of the “exporter” fold and P4-ATPases
From a distant point of view, ABC transporters of the “exporter” fold
and P4-ATPases might look as if they were similar machines: both exist
in at least two conformers with different substrate afﬁnities at each side
of the membrane and ATP provides the driving force for a conforma-
tional interchange. Generally speaking the mechanism by which both
proteins hydrolyze ATP is analogous, as can be inferred by the fact
that both types of proteins are sensitive to vanadate [130,131], which
mimics the transition state of ATP during hydrolysis [132].
A closer look reveals major differences between the transporters.
Most notably, the fate of the γ-phosphate released from the
hydrolysed ATP molecule, is very different in the two pump classes:
P4-ATPases forma phosphorylated intermediate inwhich Pi is covalently
bound to an aspartate residue located in a conserved amino acid motif
within the nucleotide binding site. Release of this Pi requires active
nucleophilic attack of a glutamic acid in the actuator domain [133]. In
contrast, covalent protein phosphorylation has not been described for
ABC transporters [74]. Further, P4-ATPases have a single location for
ATP binding, while ABC transporters feature a closed NBD dimer that is
stabilized by ATP as described in detail above. Up to now there are no
structural reports of NBDs of P-type ATPases functioning as dimers.
Moreover, in ABC exporters, ADP and Pi are suggested to be released by
electrostatic repulsions after hydrolysis [74] and therefore ATP hydroly-
sis is most probably not used for the translocation step but for resetting
the ABC transporter to its original conformation.
Despite these differences in energization, based on proteinmass and
structural models, the size of ABC exporters and P4-ATPases would be
expected to be similar in the membrane (Fig. 1E) and the models pro-
posed for explaining phospholipid transport by these two types of
transporters present some remarkable similarities. Are ABC transporters
and P4-ATPases using the same mechanism to transport phospholipids
in opposite directions?
Table 4
Available crystal structures for P-type ATPases.
Protein Subclass Conformation⁎ PDB entry⁎⁎ Reference
Na+,K+-ATPase P2 E2P 3N2F (4.10), 3 N23 (4.60), 3B8E (3.50), 3KDP (3.50),
3A3Y (2.80), 2ZXE (2.40)
[195–197]
E1P 4HQJ (4.30), 3WGU(2.80), 3WGV (2.80) [198–200]
H+-ATPase (AHA2) P3 E1 3B8C (3.60) [110]
Cu+-ATPase (CopA) P1 E2P 3RFU (3.20), 4BBJ (2.80) [201,202]
Ca2+-ATPase (SERCA) P2 E1 4H1W (3.10), 3W5A (3.01), 3W5B (3.20), 3TLM (2.95), 2C9M (3.00) [203–206]
E1P 3BA6 (2.80), 3N8G (2.59), 2DQS (2.50), 1VFP (2.90), 1T5S (2.60), 1T5T (2.90),
1SU4 (2.40)
[100,128,207–211]
E2P 4J2T (3.20), 3N5K (2.20), 3AR2 (2.50), 3AR3 (2.30), 3AR4 (2.15), 3AR5 (2.20),
3AR6 (2.20), 3AR7 (2.15), 3AR8 (2.60), 3AR9 (2.60), 3B9B (2.65), 3FGO (2.50),
3FPB (2.55), 3FPS (3.20), 3N23(4.60), 3W5D (2.45), 2ZBD (2.40), 2ZBE (3.80),
2ZBF (2.40), 2ZBG (2.55), 2O9J (2.65), 1XP5 (3.00), 1WPG (2.30)
[129,133,196,204,207,
209–214]
E2 4KYT (2.83), 2YFY (3.10), 3NAL (2.65), 3NAM (3.10), 3NAN (3.10), 3B9R (3.00),
3W5C (2.50), 2OA0 (3.40), 2EAR (3.10), 2EAS (3.40), 2EAT (2.90), 2EAU (2.80),
2C88 (3.10), 2C8K (2.80), 2C8L (3.10), 2BY4 (3.30), 2AGV (2.40), 1IWO (3.10)
[128,129,204,206,214–220]
⁎ E1 and E2 denote totally dephosphorylated pumps, while E1P and E2P indicate the phosphorylated states and the transitions states to/from dephosphorylated conformations.
⁎⁎ Numbers in brackets indicate structure resolution in Å.
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In both the “alternating accessmodel” for ABC transporters and in the
classical transport model for P4-ATPases, the phospholipid is proposed
to gain access from one side of the membrane to a central cavity inside
the transporter that is then closed and opened to the opposite side
(Fig. 1B and 1D). The cavities supposedly used to allocate the substrate
during transport would, nevertheless, be very different in size. In ABC
transporters, thewide central cavity leaves plenty of space to accommo-
date a complete phospholipid molecule. Such an opening is unlikely to
be present in P4-ATPases, yet lipids and lipid-like molecules like
thapsigargin have been found deeply embedded in the crystal structure,
suggesting a possible access pathway of the substrate to a central bind-
ing pocket, in analogy to other cation-transporting P-type ATPases.
However, a substantial amount of evidence is still required to under-
stand whether the big central cavity in ABC transporters is used for
phospholipid translocation, and whether P4-ATPases and/or ABC trans-
porters achieve an occluded state during phospholipid transport in
which the phospholipid is buried within the pump molecule.
Likewise, the substrate binding mechanism proposed for the ABC
transporter ABCB10 is similar to the non-canonical model for
P4-ATPase transport. In both, it is suggested that a lateral groove in
the transmembrane region will provide access of an amphipathic sub-
strate directly from the membrane. For P4-ATPases, this groove would
open for substrate access from the exoplasmic leaﬂet of the membrane
in the E2P phospholipid-loading conformation and to the cytosolic
leaﬂet in the E1 conformation after phospholipid release [122]. For
ABC exporters, the groove would open to the cytosolic leaﬂet in the
open-inwards, substrate-loading conformation and to the exoplasmic
leaﬂet in the open-outwards conformation [40].
Finally, although P4-ATPases only contain 10 transmembrane do-
mains, phospholipid translocation has only been shown for members of
the family that interact with a β-subunit containing two transmembrane
helices. Potentially, a total of 12 transmembrane domains might be
required for ﬂippase activity. Notably, ABC transporters related to phos-
pholipid transport also contain the same number of transmembrane
Cyt
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E2P E2 E1
N
A
P
N
A
P
N
A
P
Cyt
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E2P E2 E1
N
A
P
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1 nm
2.05 nm
K+
0.304 nm
Ca2+
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A
B
C
Fig. 3. The canonical versus the non-canonical model of lipid translocation by P4-ATPases. (A) The canonical pathway, inwhich the lipid enters the protein in away analogous to the entry
of cations in other P-type ATPases. After occlusion in the binding site, the rearrangement of the TM-domain results in opening of an exit pathwayon the opposite side of themembrane. (B)
The non-canonical pathway, in which the lipid head group is recognized by interaction with residues located in the boundary of themembrane, slides through the protein surface and is
released on the other side of the membrane after rearrangement of the TM-domain. (C) Relative sizes of various substrates transported by P-type ATPases.
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segments. Further structural and biochemical characterization will be
required to determine whether the twelve-TMD arrangement is the
minimal optimized structure that allows for phospholipid translocation.
4. Major conclusions and general signiﬁcance
Although an increasing amount of evidence is shedding light on the
way phospholipid transporters discriminate their substrates, we are still
very far from discerning the mechanism by which these substrates are
translocated across cellular membranes. Unraveling this mechanism
will require studies on the energy-dependent transporters reconstituted
into proteoliposomes, a challenging task given the difﬁculties of purify-
ing membrane proteins, the hydrophobic nature of the phospholipid
substrates and the potential requirement for subunits and/or accessory
proteins.
Promising steps have been taken to improve expression and large
scale puriﬁcation of P4-ATPases in complexwith their subunit, a prereq-
uisite for systematic crystallization trails [134]. Interestingly, a recent
publication has reported on the ability of a P4-ATPase to counteract
the toxic effects of overexpression of an ABC transporter in human
cells [135], suggesting that novel strategiesmight be required to further
improve heterologous expression production for these transporters. On
the other hand, technology developments inmembrane protein crystal-
lization and synchrotronmicrocrystallography combinedwith advance-
ments in protein stabilization using lipidic cubic phases may help to
obtain structural information with smaller amounts of startingmaterial
[136]. Recent progress in the functional reconstitution of ABC trans-
porters and P4-ATPases into vesicles and nanodiscs might allow in the
near future for systematic studies aiming at identifying the phospholipid
binding sites and at testing the existence of an occlusion state for the
substrate during transport.
Finally, most evidence on phospholipid transport is based on labeled
lipid analogs. In the future, new approaches will be needed to measure
transbilayer phospholipid movement using natural phospholipids, such
as shape-change visualization experiments in giant unilamellar vesicles.
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